National and Kapodistrian University of Athens
Διερεύνηση του ρόλου του συστήματος CD40, προ-φλεγμονωδών και φλεγμονωδών κυτοκινών στην ανάπτυξη χαμηλού βαθμού φλεγμονής σε ασθενείς με διαβήτη τύπου 1
Abstract
dc:descriptionType 1 Diabetes is characterized by low grade inflammation, which is confirmed by high levels of inflammatory markers such as C-reactive protein (CRP) in diabetic patients and seems to be linked to the initiation and development of disease’s complications such as cardiovascular disease and diabetic nephropathy. CD40, a transmembrane receptor of the tumor necrosis factor (TNF) gene superfamily is expressed on a variety of cells, such as monocytes, B-cells, antigen presenting cells, endothelial, smooth muscle cells and fibroblasts and implicated in chronic inflammatory and autoimmune diseases, such as type 1 Diabetes. The aim of this thesis was: 1) to determine the regulation of CD40 in transcriptional, translational and post-translational level and its association with parameters such as diabetes duration, metabolic control, glycosylated hemoglobin (HbA1c) etc., so as to define the pathophysiological relationship between CD40 and low-grade diabetic inflammation 2) To assess the nature of diabetic inflammation and the involvement of specific mediators in this, by determining a large number of inflammatory and anti-inflammatory cytokines and their correlation with CD40. 3) To study possible changes in the levels of cytokines between patients with diabetes duration of 0-6 months (period of remission of the disease) and those with diabetes duration longer than 6 months (period of established disease), in order to identify which of them probably mediates the destruction of the remaining b-cells, which still exist at the time of diagnosis. Plasma, urine and peripheral blood mononuclear cells from 70 type 1 diabetic patients without established complications and from 40 healthy controls were used for the experiments. The latter included techniques such as ELISA, Western blot, RTPCR, endonuclease digestion, sequencing and protein arrays, in order to determine a) the levels of soluble CD40 in plasma and urine of diabetic patients and healthy controls, b) the quantity of cellular CD40 and the pattern and relative amount of CD40 mRNA isoforms in peripheral blood mononuclear cells and c) the concentrations of IL-1a, IL-1b, IL -2, IL -4, IL -5, IL -6, IL -8, IL -10, IL -12, IL -13, GM-CSF, GRO, IFN-c, MCP-1, MIP-1a, MIP-1b, RANTES, TNF-a, MMP-9, VEGF in plasma of diabetic patients and healthy controls. The conclusions of this work are summarized as follows: 21 1) Hyperglycaemia affects the transcriptional and translational control of CD40 system both in vivo and in vitro, since CD40 levels were elevated in plasma, urine and cells of diabetic patients and associated with glycosylated haemoglobin and also increased secretion of CD40 was observed in culture supernatants of peripheral blood mononuclear cells under conditions of hyperglycaemia. Furthermore a strong positive correlation was found between poor glycemic control of patients and the absence of CD40-isoform, which has an inhibitory role in the progress of inflammatory processes. Therefore, the homeostatic dysregulation of CD40 system under conditions of hyperglycaemia is implicated in the establishment of an increased inflammatory activity in the body, which contributes to the initiation and progress of type 1 diabetic complications
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Χατζηγεωργίου, Αντώνιος
- Chatzigeorgiou, Antonios
Subjects
dc:subject × 20- Σακχαρώδης διαβήτης τύπου 1
- Φλεγμονές
- Κυτοκίνες
- Ιντερλευκίνες
- Χημειοκίνες
- Σύστημα CD40
- Υπεργλυκαιμία
- Αυτοανοσία
- Type I, Diabetes mellitus
- Inflammation
- Cytokines
- Interleukins
- Chemokines
- CD40 system
- Hyperglycemia
- Autoimmunity
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24360